Legislative Research: KY HB910 | 2026 | Regular Session

Other Sessions

SessionTitle/DescriptionLast Action
2026
Regular Session

(Introduced)
Amend KRS 218A.500 to provide that drug testing products that are used or intended for use to determine whether a substance contains a controlled substance, synthetic drug, or any chemical or compound that may cause physical harm or death shall not b...
[HB910 2026 Detail][HB910 2026 Text][HB910 2026 Comments]
2026-03-11
to Judiciary (H)

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[Kentucky HB910]Google WebGoogle News
[Kentucky House Judiciary Committee]Google WebGoogle NewsFollowTheMoney
[Representative Emily Callaway KY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Representative Kimberly Moser KY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Representative Robert Duvall KY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
KY HB910 | 2026 | Regular Session. (2026, March 11). LegiScan. Retrieved June 14, 2026, from https://legiscan.com/KY/bill/HB910/2026
MLA
"KY HB910 | 2026 | Regular Session." LegiScan. LegiScan LLC, 11 Mar. 2026. Web. 14 Jun. 2026. <https://legiscan.com/KY/bill/HB910/2026>.
Chicago
"KY HB910 | 2026 | Regular Session." March 11, 2026 LegiScan. Accessed June 14, 2026. https://legiscan.com/KY/bill/HB910/2026.
Turabian
LegiScan. KY HB910 | 2026 | Regular Session. 11 March 2026. https://legiscan.com/KY/bill/HB910/2026 (accessed June 14, 2026).

Subjects


Kentucky State Sources


feedback